303810 — Dongkook Life Science Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Dongkook Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,223	1,381	3,424	2,403
Net Total Accounts Receivable
Net Total Receivables	48,410	48,588	58,354	65,416
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	79,403	83,854	102,920	115,658
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	54,218	65,106	64,749	64,700
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	147,894	164,434	179,129	191,658
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	76,785	73,830	91,406	62,881
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	87,425	99,305	110,425	86,433
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	60,469	65,129	68,704	105,224
Total Liabilities & Shareholders' Equity	147,894	164,434	179,129	191,658
Total Common Shares Outstanding